Screener
Apogee Therapeutics, Inc. APGE Enterprise value
Enterprise value at other companies
Other financials
Where this comes from
Calculated from Apogee Therapeutics, Inc.’s reported figures.
The source filing: Apogee Therapeutics, Inc.’s 10-Q, filed May 11, 2026. Open the filing →
- Filed
- May 11, 2026, 7:20 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-215698
FAQ
- What is Apogee Therapeutics, Inc.'s enterprise value?
- Apogee Therapeutics, Inc. (APGE) reported enterprise value of $5.84B in Q1 2026.
- How has Apogee Therapeutics, Inc.'s enterprise value changed year-over-year?
- Apogee Therapeutics, Inc.'s enterprise value increased by 181.2% year-over-year, from $2.08B to $5.84B.
- What is the long-term trend for Apogee Therapeutics, Inc.'s enterprise value?
- Over 2 years (2023 to 2025), Apogee Therapeutics, Inc.'s enterprise value has grown at a 102.7% compound annual growth rate (CAGR), from $1.23B to $5.03B.
- What does enterprise value mean?
- Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.
Ask your AI about Apogee Therapeutics, Inc.'s enterprise value.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude